Zobrazeno 1 - 10
of 45
pro vyhledávání: '"T J, Priestman"'
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 26(10)
Publikováno v:
Clinical Oncology. 8:308-315
Between February 1990 and February 1993, 25 centres in the UK recruited 544 patients into a prospective randomized trial comparing two whole-brain radiotherapy regimens (30 Gy in ten fractions over 2 weeks versus 12 Gy in two fractions on consecutive
Autor:
T J, Priestman
Publikováno v:
The Canadian journal of oncology. 6
A number of different palliative radiotherapy techniques and fractionation schedules have been used in the UK over the past several years. In an attempt to standardize treatment practices, a handful of studies have been conducted in recent years comp
Publikováno v:
The Canadian journal of oncology. 6
Painful bone metastases are a clear indication for the use of radiotherapy, with reported response rates of up to 85% of patients treated. In an attempt to define the optimal use of palliative radiotherapy when used in this situation, the data for th
Autor:
T J, Priestman
Publikováno v:
The Canadian journal of oncology. 6
A significant number of cancer patients undergoing palliative radiotherapy experience treatment-related nausea and vomiting. A number of factors are known to influence the incidence and severity of radiation-induced sickness including the site, field
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 5(3)
During the 1980s a number of studies suggested there might be a role for interferon in the treatment of high grade gliomas. In the light of these reports a formal Phase II evaluation of human lymphoblastoid interferon (Wellferon) was undertaken in pa
Publikováno v:
Clinical Oncology. 9:135
A small series of breast carcinomas in which more node-negative cases presented in the left breast and more node-positive in the right has been extended to include 161 cases, 96% of all presenting in the district over a 12 month period. The previous
Publikováno v:
British Journal of Cancer
A loading dose of MPA employing a regimen of 1,000 mg six hourly for 8 doses can achieve plateau levels above 100 ng ml-1 within the first 36 h of treatment, without any untoward toxicity. This raises the possibility of shortening the time to respons
Autor:
T J Priestman
Publikováno v:
Journal of the Royal Society of Medicine. 71:195-198
Publikováno v:
Cancer. 51:273-276
Seventeen patients with metastatic disease from malignant melanoma received treatment with injections of Human lymphoblastoid interferon. Fifteen of these had the drug by intramuscular injections. One started treatment by the intramuscular route but